A detailed history of Mc Carthy & Cox transactions in Eli Lilly & CO stock. As of the latest transaction made, Mc Carthy & Cox holds 233 shares of LLY stock, worth $174,286. This represents 0.08% of its overall portfolio holdings.

Number of Shares
233
Holding current value
$174,286
% of portfolio
0.08%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$772.14 - $960.02 $179,908 - $223,684
233 New
233 $207 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Mc Carthy & Cox Portfolio

Follow Mc Carthy & Cox and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Carthy & Cox, based on Form 13F filings with the SEC.

News

Stay updated on Mc Carthy & Cox with notifications on news.